|
|
|
|
β1-adrenoceptor
|
|
|
Hs |
Antagonist |
Partial agonist |
9.1 – 10.0 |
pA2 |
- |
8,10-13 |
|
| ⤷ |
pA2
9.1 – 10.0
[8,10-13]
|
|
β2-adrenoceptor
|
|
|
Hs |
Antagonist |
Partial agonist |
8.9 – 10.0 |
pA2 |
- |
7,13 |
|
| ⤷ |
pA2
8.9 – 10.0
[7,13]
|
|
β1-adrenoceptor
|
|
|
Hs |
Antagonist |
Partial agonist |
9.3 – 9.4 |
pKi |
- |
3-6,10,12,15-17,20,23-24 |
|
| ⤷ |
pKi
9.3 – 9.4
[3-6,10,12,15-17,20,23-24]
|
|
β2-adrenoceptor
|
|
|
Hs |
Agonist |
Partial agonist |
8.4 – 9.8 |
pKi |
- |
3,5,10,15,20-22,24 |
|
| ⤷ |
pKi
8.4 – 9.8
[3,5,10,15,20-22,24]
|
|
β2-adrenoceptor
|
|
|
Hs |
Antagonist |
Partial agonist |
8.4 – 9.8 |
pKi |
- |
3,5,7,10,20,24 |
|
| ⤷ |
pKi
8.4 – 9.8
[3,5,7,10,20,24]
|
|
β1-adrenoceptor
|
|
|
Hs |
Agonist |
Partial agonist |
8.3 – 9.4 |
pKi |
- |
3-6,10,12,15-17,20,23-24 |
|
| ⤷ |
pKi
8.3 – 9.4
[3-6,10,12,15-17,20,23-24]
|
|
β3-adrenoceptor
|
|
|
Hs |
Antagonist |
Partial agonist |
7.0 – 7.3 |
pKi |
- |
3,14-15,17-19,24 |
|
| ⤷ |
pKi
7.0 – 7.3
[3,14-15,17-19,24]
|
|
β3-adrenoceptor
|
|
|
Hs |
Agonist |
Partial agonist |
7.0 – 7.1 |
pKi |
- |
3,14-15,18-19,24 |
|
| ⤷ |
pKi
7.0 – 7.1
[3,14-15,18-19,24]
|
|
β3-adrenoceptor
|
|
|
Mm |
Agonist |
Partial agonist |
6.8 |
pKi |
- |
14,18 |
|
| ⤷ |
pKi
6.8
[14,18]
|
|
β3-adrenoceptor
|
|
|
Mm |
Antagonist |
Partial agonist |
6.8 |
pKi |
- |
14,24 |
|
| ⤷ |
pKi
6.8
[14,24]
|
|
β2-adrenoceptor
|
|
|
Hs |
Agonist |
Partial agonist |
8.3 – 9.7 |
pEC50 |
- |
5,7,9-10,13,21 |
|
| ⤷ |
pEC50
8.3 – 9.7
[5,7,9-10,13,21]
|
|
β1-adrenoceptor
|
|
|
Hs |
Agonist |
Partial agonist |
7.4 – 9.1 |
pEC50 |
- |
2,5,8,10-13,21 |
|
| ⤷ |
pEC50
7.4 – 9.1
[2,5,8,10-13,21]
|
|
β3-adrenoceptor
|
|
|
Mm |
Agonist |
Partial agonist |
7.4 |
pEC50 |
- |
14,18 |
|
| ⤷ |
pEC50
7.4
[14,18]
|
|
β3-adrenoceptor
|
|
|
Hs |
Agonist |
Partial agonist |
6.6 – 7.0 |
pEC50 |
- |
1,4,14,18 |
|
| ⤷ |
pEC50
6.6 – 7.0
[1,4,14,18]
|
|